• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/5/21 4:29:22 PM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $YI alert in real time by email
    SC 13G/A 1 tm215528d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 2)*

     

    111, Inc.

    (Name of Issuer)

     

    Class A Ordinary Shares, par value US$0.00005 per share

    (Title of Class of Securities)

     

    68247Q 102**

    (CUSIP Number)

     

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ¨ Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    x Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    ** This CUSIP applies to the American Depositary Shares (“ADSs”), each representing two Class A ordinary shares of the Issuer. No CUSIP has been assigned to the Class A ordinary shares.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     


    CUSIP No. 68247Q102
     
      1.

    Names of Reporting Persons

    ClearVue YW Holdings, Ltd.

     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) o
        (b) x(1)
     
      3. SEC Use Only
     
      4.

    Citizenship or Place of Organization

    Cayman Islands

       

     

     

    Number of Shares Beneficially Owned by Each Reporting Person With 5.

    Sole Voting Power

     

    0

     

     
      6.

    Shared Voting Power

    18,945,628 Class A ordinary shares (2)

     

     
      7.

    Sole Dispositive Power

    0

     

     
      8.

    Shared Dispositive Power

    18,945,628 Class A ordinary shares (2)

     

     
      9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    18,945,628 Class A ordinary shares (2)

     

      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)o
      11.

    Percent of Class Represented by Amount in Row (9)

    20.6% of Class A ordinary shares (or 11.5% of the total ordinary shares) (3)

      12.

    Type of Reporting Person (See Instructions)

    CO

               
    (1)This statement on Schedule 13G is filed by ClearVue YW Holdings, Ltd. (“ClearVue Holdings”), ClearVue Partners, L.P. (“ClearVue Fund I”), ClearVue Partners GP, L.P. (“ClearVue I GP”), ClearVue Partners Ltd. (“ClearVue I GPGP”) and Harry Chi Hui (“Hui”, collectively with ClearVue Holdings, ClearVue Fund I, ClearVue I GP and ClearVue I GPGP, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of (i) 15,100,646 Class A ordinary shares held by ClearVue Holdings and (ii) 1,922,491 ADSs (representing 3,844,982 Class A ordinary shares) held by ClearVue Holdings. ClearVue Holdings is wholly owned by ClearVue Fund I, and as such, ClearVue Fund I may exercise voting and dispositive power over these shares held by ClearVue Holdings. ClearVue I GP is the general partner of ClearVue Fund I, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings by way of ClearVue Fund I and the shares held by ClearVue Fund I. ClearVue I GP GP is the general partner of ClearVue I GP, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I by way of ClearVue I GP. Hui owns 60% of the equity interest in ClearVue I GPGP, and as such, may be deemed to share voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I.
    (3)The beneficial ownership percentage of Class A ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares as reported in the Issuer’s annual report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on April 16, 2020 (the “Issuer’s 20-F Filing”). The beneficial ownership percentage of the total ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares and 72,000,000 outstanding Class B ordinary shares as reported in the Issuer’s 20-F Filing. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to fifteen votes, voting together as one class. Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. Accordingly, and based on the foregoing, the Class A ordinary shares beneficially owned by the Reporting Persons represent approximately 1.6% of the aggregate voting power of the total issued and outstanding ordinary shares of the Issuer.

     

     

     

     

    CUSIP No. 68247Q102
     
      1.

    Names of Reporting Persons

    ClearVue Partners, L.P.

     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ¨
        (b) x(1)
     
      3. SEC Use Only
     
      4.

    Citizenship or Place of Organization

    Cayman Islands

       

     

     

    Number of Shares Beneficially Owned by Each Reporting Person With 5.

    Sole Voting Power

     

    0

     

     
      6.

    Shared Voting Power

    18,946,636 Class A ordinary shares (2) 

     
      7.

    Sole Dispositive Power

    0

     

     
      8.

    Shared Dispositive Power

    18,946,636 Class A ordinary shares (2) 

     
      9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    18,946,636 Class A ordinary shares (2)

      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)o
      11.

    Percent of Class Represented by Amount in Row (9)

    20.6% of Class A ordinary shares (or 11.5% of the total ordinary shares) (3)

      12.

    Type of Reporting Person (See Instructions)

    PN

               
    (1)This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of (i) 15,100,646 Class A ordinary shares held by ClearVue Holdings, (ii) 1,922,491 ADSs (representing 3,844,982 Class A ordinary shares) held by ClearVue Holdings, and (iii) 504 ADSs (representing 1,008 Class A ordinary shares) held by held by ClearVue Holdings. ClearVue Holdings is wholly owned by ClearVue Fund I, and as such, ClearVue Fund I may exercise voting and dispositive power over these shares held by ClearVue Holdings. ClearVue I GP is the general partner of ClearVue Fund I, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings by way of ClearVue Fund I and the shares held by ClearVue Fund I. ClearVue I GP GP is the general partner of ClearVue I GP, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I by way of ClearVue I GP. Hui owns 60% of the equity interest in ClearVue I GPGP, and as such, may be deemed to share voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I.
    (3)The beneficial ownership percentage of Class A ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares as reported in the Issuer’s 20-F Filing. The beneficial ownership percentage of the total ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares and 72,000,000 outstanding Class B ordinary shares as reported in the Issuer’s 20-F Filing. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to fifteen votes, voting together as one class. Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. Accordingly, and based on the foregoing, the Class A ordinary shares beneficially owned by the Reporting Persons represent approximately 1.6% of the aggregate voting power of the total issued and outstanding ordinary shares of the Issuer.

     

     

     

     

    CUSIP No. 68247Q102
     
      1.

    Names of Reporting Persons

    ClearVue Partners GP, L.P.

     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ¨
        (b) x(1)
     
      3. SEC Use Only
     
      4.

    Citizenship or Place of Organization

    Cayman Islands

       

     

     

    Number of Shares Beneficially Owned by Each Reporting Person With 5.

    Sole Voting Power

     

    0

     

     
      6.

    Shared Voting Power

    18,946,636 Class A ordinary shares (2) 

     
      7.

    Sole Dispositive Power

    0

     

     
      8.

    Shared Dispositive Power

    18,946,636 Class A ordinary shares (2) 

     
      9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    18,946,636 Class A ordinary shares (2)

      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)o
      11.

    Percent of Class Represented by Amount in Row (9)

    20.6% of Class A ordinary shares (or 11.5% of the total ordinary shares) (3)

      12.

    Type of Reporting Person (See Instructions)

    PN

               
    (1)This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of (i) 15,100,646 Class A ordinary shares held by ClearVue Holdings, (ii) 1,922,491 ADSs (representing 3,844,982 Class A ordinary shares) held by ClearVue Holdings, and (iii) 504 ADSs (representing 1,008 Class A ordinary shares) held by held by ClearVue Holdings. ClearVue Holdings is wholly owned by ClearVue Fund I, and as such, ClearVue Fund I may exercise voting and dispositive power over these shares held by ClearVue Holdings. ClearVue I GP is the general partner of ClearVue Fund I, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings by way of ClearVue Fund I and the shares held by ClearVue Fund I. ClearVue I GP GP is the general partner of ClearVue I GP, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I by way of ClearVue I GP. Hui owns 60% of the equity interest in ClearVue I GPGP, and as such, may be deemed to share voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I.
    (3)The beneficial ownership percentage of Class A ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares as reported in the Issuer’s 20-F Filing. The beneficial ownership percentage of the total ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares 72,000,000 outstanding Class B ordinary shares as reported in the Issuer’s 20-F Filing. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to fifteen votes, voting together as one class. Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. Accordingly, and based on the foregoing, the Class A ordinary shares beneficially owned by the Reporting Persons represent approximately 1.6% of the aggregate voting power of the total issued and outstanding ordinary shares of the Issuer.

     

     

     

     

    CUSIP No. 68247Q102
     
      1.

    Names of Reporting Persons

    ClearVue Partners Ltd.

     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ¨
        (b) x(1)
     
      3. SEC Use Only
     
      4.

    Citizenship or Place of Organization

    Cayman Islands

       

     

     

    Number of Shares Beneficially Owned by Each Reporting Person With 5.

    Sole Voting Power

     

    0

     

     
      6.

    Shared Voting Power

    18,946,636 Class A ordinary shares (2) 

     
      7.

    Sole Dispositive Power

    0

     

     
      8.

    Shared Dispositive Power

    18,946,636 Class A ordinary shares (2) 

     
      9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    18,946,636 Class A ordinary shares (2)

      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)o
      11.

    Percent of Class Represented by Amount in Row (9)

    20.6% of Class A ordinary shares (or 11.5% of the total ordinary shares) (3)

      12.

    Type of Reporting Person (See Instructions)

    CO

               
    (1)This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of (i) 15,100,646 Class A ordinary shares held by ClearVue Holdings, (ii) 1,922,491 ADSs (representing 3,844,982 Class A ordinary shares) held by ClearVue Holdings, and (iii) 504 ADSs (representing 1,008 Class A ordinary shares) held by held by ClearVue Holdings. ClearVue Holdings is wholly owned by ClearVue Fund I, and as such, ClearVue Fund I may exercise voting and dispositive power over these shares held by ClearVue Holdings. ClearVue I GP is the general partner of ClearVue Fund I, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings by way of ClearVue Fund I and the shares held by ClearVue Fund I. ClearVue I GP GP is the general partner of ClearVue I GP, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I by way of ClearVue I GP. Hui owns 60% of the equity interest in ClearVue I GPGP, and as such, may be deemed to share voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I.
    (3)The beneficial ownership percentage of Class A ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares as reported in the Issuer’s 20-F Filing. The beneficial ownership percentage of the total ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares and 72,000,000 outstanding Class B ordinary shares as reported in the Issuer’s 20-F Filing. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to fifteen votes, voting together as one class. Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. Accordingly, and based on the foregoing, the Class A ordinary shares beneficially owned by the Reporting Persons represent approximately 1.6% of the aggregate voting power of the total issued and outstanding ordinary shares of the Issuer.

     

     

     

     

    CUSIP No. 68247Q102
     
      1.

    Names of Reporting Persons

    Harry Chi Hui

     
      2. Check the Appropriate Box if a Member of a Group (See Instructions)
        (a) ¨
        (b) x(1)
     
      3. SEC Use Only
     
      4.

    Citizenship or Place of Organization

    Hong Kong

       

     

     

    Number of Shares Beneficially Owned by Each Reporting Person With 5.

    Sole Voting Power

     

    0

     

     
      6.

    Shared Voting Power

    18,946,636 Class A ordinary shares (2)

     
      7.

    Sole Dispositive Power

    0

     

     
      8.

    Shared Dispositive Power

    18,946,636 Class A ordinary shares (2)

     
      9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    18,946,636 Class A ordinary shares (2)

      10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)o
      11.

    Percent of Class Represented by Amount in Row (9)

    20.6% of Class A ordinary shares (or 11.5% of the total ordinary shares) (3)

      12.

    Type of Reporting Person (See Instructions)

    IN

               
    (1)This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of (i) 15,100,646 Class A ordinary shares held by ClearVue Holdings, (ii) 1,922,491 ADSs (representing 3,844,982 Class A ordinary shares) held by ClearVue Holdings, and (iii) 504 ADSs (representing 1,008 Class A ordinary shares) held by held by ClearVue Holdings. ClearVue Holdings is wholly owned by ClearVue Fund I, and as such, ClearVue Fund I may exercise voting and dispositive power over these shares held by ClearVue Holdings. ClearVue I GP is the general partner of ClearVue Fund I, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings by way of ClearVue Fund I and the shares held by ClearVue Fund I. ClearVue I GP GP is the general partner of ClearVue I GP, and as such, may exercise voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I by way of ClearVue I GP. Hui owns 60% of the equity interest in ClearVue I GPGP, and as such, may be deemed to share voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I.
    (3)The beneficial ownership percentage of Class A ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares as reported in the Issuer’s 20-F Filing. The beneficial ownership percentage of the total ordinary shares is calculated based on 92,120,024 outstanding Class A ordinary shares and 72,000,000 outstanding Class B ordinary shares as reported in the Issuer’s 20-F Filing. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to fifteen votes, voting together as one class. Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. Accordingly, and based on the foregoing, the Class A ordinary shares beneficially owned by the Reporting Persons represent approximately 1.6% of the aggregate voting power of the total issued and outstanding ordinary shares of the Issuer.

     

     

     

     

    CUSIP No. 68247Q102

     

    Item 1.
      (a)

    Name of Issuer

    111, Inc. (the “Issuer”)

     

      (b)

    Address of Issuer’s Principal Executive Offices

    3-4/F, No.295 ZuChongZhi Road, Pudong New Area, Shanghai, People’s Republic of China

     

    Item 2.
      (a)

    Name of Person Filing

     

    ClearVue YW Holdings, Ltd. (“ClearVue Holdings”)

    ClearVue Partners, L.P. (“ClearVue Fund I”)

    ClearVue Partners GP, L.P. (“ClearVue I GP”)

    ClearVue Partners Ltd. (“ClearVue I GPGP”)

    Harry Chi Hui (“Hui”)

    (collectively, the “Reporting Persons”)

     

      (b)

    Address of Principal Business Office or, if none, Residence

     

    The address of each of ClearVue YW Holdings, Ltd., ClearVue Partners, L.P., ClearVue Partners GP, L.P. and ClearVue Partners Ltd. is:

    Harneys Fiduciary (Cayman) Limited

    4th Floor, Harbour Place, 103 South Church Street,

    P.O. Box 10240, Grand Cayman KY1-1002,

    Cayman Islands

     

    The address of Harry Chi Hui is:

    Unit 902, No.1717, West Nanjing Road,

    Shanghai, China

     

      (c)

    Citizenship

     

    ClearVue YW Holdings, Ltd.: Cayman Islands

    ClearVue Partners, L.P.: Cayman Islands

    ClearVue Partners GP, L.P.: Cayman Islands

    ClearVue Partners Ltd.: Cayman Islands

    Harry Chi Hui: Hong Kong

     

      (d)

    Title of Class of Securities

    Class A Ordinary Shares, par value US$0.00005 per share

     

      (e)

    CUSIP Number

    There is no CUSIP number assigned to the Class A ordinary shares. CUSIP number 68247Q102 has been assigned to the ADSs of the Issuer, which are quoted on The Nasdaq Global Select Market under the symbol “YI.” Each ADS represents two Class A ordinary shares.

     
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
      Not applicable.

     

     

     

     

    Item 4.Ownership

     

    The following information with respect to the ownership of Class A ordinary shares by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2020:

     

    Reporting Persons Ordinary
    Shares Held
    Directly (1)
    Shared Voting
    Power (1)
    Shared
    Dispositive
    Power (1)
    Beneficial
    Ownership (1)

    Percentage

    of Class A
    Ordinary
    Shares(1)(6)

    Percentage
    of Total
    Ordinary
    Shares (1)(6)
    Percentage
    of the
    Aggregate
    Voting
    Power(1)(6)
    ClearVue YW Holdings, Ltd. 18,945,628 18,945,628 18,945,628 18,945,628 20.6% 11.5% 1.6%
    ClearVue Partners, L.P. (2) 1,008 18,946,636 18,946,636 18,946,636 20.6% 11.5% 1.6%
    ClearVue Partners GP, L.P. (3) 0 18,946,636 18,946,636 18,946,636 20.6% 11.5% 1.6%
    ClearVue Partners Ltd.(4) 0 18,946,636 18,946,636 18,946,636 20.6% 11.5% 1.6%
    Harry Chi Hui (5) 0 18,946,636 18,946,636 18,946,636 20.6% 11.5% 1.6%

     

    (1)Represents the number of Class A ordinary shares (including Class A ordinary shares represented by ADSs) directly held by the Reporting Persons as of December 31, 2020.
    (2)ClearVue Holdings is wholly owned by ClearVue Fund I, and as such, may exercise voting and dispositive power over these shares held by ClearVue Holdings.
    (3)ClearVue I GP is the general partner of ClearVue Fund I, and as such, may exercise voting and dispositive power over the shares held by ClearVue Fund I and the shares held by ClearVue Holdings by way of ClearVue Fund I.
    (4)ClearVue I GP GP is the general partner of ClearVue I GP, and as such, may exercise voting and dispositive power over these shares held by ClearVue Fund I and ClearVue Holdings by way of ClearVue I GP.
    (5)Hui owns 60% of the equity interest in ClearVue I GPGP, and as such, may be deemed to share voting and dispositive power over the shares held by ClearVue Holdings and ClearVue Fund I.
    (6)The Reporting Persons in the aggregate beneficially own 20.6% of the outstanding Class A ordinary shares, 11.5% of the total outstanding ordinary shares and 1.6% of the aggregate voting power. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G. Each of the Reporting Persons may be deemed to beneficially own the percentage of Class A ordinary shares listed above which is calculated based on 92,120,024 outstanding Class A ordinary shares as reported in the Issuer’s 20-F Filing. Each of the Reporting Persons may be deemed to beneficially own the percentage of the total ordinary shares listed above which is calculated based on 92,120,024 outstanding Class A ordinary shares and 72,000,000 outstanding Class B ordinary shares as reported in the Issuer’s 20-F Filing. Each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to fifteen votes, voting together as one class. Accordingly, and based on the foregoing, each of the Reporting Persons may be deemed to beneficially own the percentage of the aggregate voting power of the total issued and outstanding ordinary shares of the Issuer listed above. Each ordinary share (Class A ordinary share or Class B ordinary share) has a par value of US$0.00005.

     

    Item 5. Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.
    Item 6. Ownership of More than Five Percent on Behalf of Another Person
    Not Applicable
     
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
    Not Applicable
     
    Item 8. Identification and Classification of Members of the Group
    Not Applicable
     
    Item 9. Notice of Dissolution of Group
    Not Applicable
     
    Item 10. Certification
    Not Applicable

     

     

     

     

    Exhibits:

     

    Exhibit I:        Joint Filing Agreement by and among ClearVue YW Holdings, Ltd, ClearVue Partners, L.P., ClearVue Partners GP, L.P., ClearVue Partners Ltd. and Harry Chi Hui (incorporated by reference to Exhibit I to the Schedule 13G filed with the U.S. Securities and Exchange Commission by the Reporting Persons on February 11, 2019)

     

     

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 5, 2021

     

    ClearVue YW Holdings, Ltd. 

     

    By: /s/ William Chen  
    Name:    William Chen  
    Title: Director  

     

    ClearVue Partners, L.P. 

    By: ClearVue Partners GP, L.P.

    By: ClearVue Partners Ltd.

     

    By: /s/ William Chen  
    Name: William Chen  
    Title: Director  

     

    ClearVue Partners GP, L.P.

    By: ClearVue Partners Ltd.

     

    By: /s/ William Chen  
    Name: William Chen  
    Title: Director  

     

    ClearVue Partners Ltd.

     

    By: /s/ William Chen  
    Name: William Chen  
    Title: Director  

     

    /s/ Harry Chi Hui  
    Harry Chi Hui  

     

     

     

    Get the next $YI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $YI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $YI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on 111, Inc. with a new price target

    Citigroup resumed coverage of 111, Inc. with a rating of Buy and set a new price target of $16.00

    4/15/21 6:56:01 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $YI
    SEC Filings

    View All

    SEC Form 6-K filed by 111 Inc.

    6-K - 111, Inc. (0001738906) (Filer)

    12/17/25 6:13:16 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 6-K filed by 111 Inc.

    6-K - 111, Inc. (0001738906) (Filer)

    9/17/25 6:09:10 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form 20-F/A filed by 111 Inc.

    20-F/A - 111, Inc. (0001738906) (Filer)

    8/29/25 6:03:53 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $YI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    111, Inc. Announces Third Quarter 2025 Unaudited Financial Results

    Transition from An Asset-Heavy Business Model to An Asset-Light Business ModelAchieved Quarterly Non-GAAP Net ProfitabilityMaintained Non-GAAP Operational Profitability for Three Consecutive QuartersAchieved Quarterly Positive Operating Cash FlowSHANGHAI, Dec. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Total operating expenses were RMB180.3 million (US$25.3 million)

    12/17/25 1:00:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    111, Inc. Announces Second Quarter 2025 Unaudited Financial Results

    Maintained Quarterly Operational ProfitabilityOperating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoYMaintained Positive Operating Cash Flow in the First Half of the YearSHANGHAI, Sept. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Total operating expenses were RMB185.3 million (US$25.9 million), an improvement of 9.3% compared to RMB204.3 million in

    9/17/25 2:00:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    111, Inc. Announces First Quarter 2025 Unaudited Financial Results

    Maintained Quarterly Operational ProfitabilityOperating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoYMaintained Quarterly Positive Operating Cash FlowSHANGHAI, June 19, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Net revenues were RMB3.5 billion (US$486.3 million), remaining relatively flat compared to the same quarter last year.Total operating expenses

    6/19/25 3:03:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $YI
    Financials

    Live finance-specific insights

    View All

    111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

    Achieved First-Ever Annual Operating ProfitBottom Line Improved by RMB332.7 Million YoY in 2024Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoYAchieved First-Ever Annual Positive Operating Cash FlowSHANGHAI, March 20, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Four

    3/20/25 1:00:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow

    SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 20, 2025 (7:30 PM Beijing Time on the same day). Details for the conference call are as follows: Conference Topic: 111, Inc. Fourth Q

    2/20/25 5:00:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

    Maintained Operational Profitability for the Third Consecutive QuarterOperating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoYHeld Positive Operating Cash Flow for Three Consecutive QuartersSHANGHAI, Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Net revenues were RMB3.6 billion (US$513.1 million), remaining relatively flat compared to the same

    11/27/24 1:00:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $YI
    Leadership Updates

    Live Leadership Updates

    View All

    111, Inc. Announces Change to Board of Directors

    SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that Dr. Leon Lian Yong Chen has tendered his resignation from the position as the Company's director for personal reasons, effective on November 4, 2024. The board has also appointed Mr. Yang "Luke" Chen, currently serving as the Company's Senior Finance Executive, as a new director, effective November 4, 2024. Dr. Lian Yong Chen has served on the board of directors of the Company since May 2019. "I am grateful to Dr

    11/4/24 5:00:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    111 Announces Appointment of New Auditor

    SHANGHAI, July 19, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced  the appointment of  Grant Thornton Zhitong Certified Public Accountants LLP ("Grant Thornton") as the Company's independent registered public accounting firm, effective July 19, 2024, replacing Deloitte Touche Tohmatsu Certified Public Accountants LLP. The change of the Company's independent registered public accounting firm was made after a careful and thorough evaluation process and has been approved by 111's boar

    7/19/24 8:45:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

    SHANGHAI, Sept. 23, 2022 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), consisting of three independent directors, Mr. Jian Sun, who is the chairman of the Special Committee, Mr. Nee Chuan Teo and Mr. Jun Luo, established by the Company's Board of Directors (the "Board") has retained Houlihan Lokey China Limited as its independent financial advisor and Kirkland & Ellis as its U.S. legal counsel in connection with its review and evaluation of the previously announced preliminary non-binding proposal letter dated September 9, 2022 (the "Proposal")

    9/23/22 12:30:00 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $YI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by 111 Inc. (Amendment)

    SC 13D/A - 111, Inc. (0001738906) (Subject)

    2/27/24 8:02:40 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13D/A filed by 111 Inc. (Amendment)

    SC 13D/A - 111, Inc. (0001738906) (Subject)

    7/17/23 9:00:05 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13D/A filed by 111 Inc. (Amendment)

    SC 13D/A - 111, Inc. (0001738906) (Subject)

    10/31/22 7:57:04 AM ET
    $YI
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples